-The Times of India This may come as a shocker. Newer and more expensive categories of insulin are being aggressively "pushed" by drug companies, and, hence, increasingly prescribed by physicians for diabetics. The newer, second generation (rapid and long acting) versions are priced around Rs 500, three to four times costlier than the older versions - increasing the cost of treatment. Diabetes is growing alarmingly in India, with over 65 million...

-The Times of India NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics. "There is a need to review the implementation of DPCO (Drugs Price...

-Business Standard Health cess recommended; public health care to be primary focus The National Democratic Alliance (NDA) government plans to increase public investment in health from 1.04 per cent of GDP (gross domestic product) to 2.5 per cent by 2020, with 70 per cent of this being dedicated to primary health care. This target has been set in the overhauled draft National Health Policy that now emphasises on substantially ratcheting up government...

-The Times of India MUMBAI/NEW DELHI: Medicines widely used to treat diabetes, infections, pain and digestive disorders will cost 5-40% less with immediate effect, with the drug price regulator issuing an order to fix the prices of 39-odd formulations. The National Pharmaceutical Pricing Authority's (NPPA) order, issued on Wednesday, includes drug combinations such as ciprofloxacin hydrochloride, cefotaxime, paracetamol, domperidone and metformin + glimepiride and amoxycillin + potassium clavulanate. These drugs and combinations are...

-Tehelka The NDA government’s move to open more Jan Aushadhi stores ignores the multitude of issues currently plaguing them Amidst the jostling crowd at the Guru Teg Bahadur Hospital in Shahdara, Delhi, is 68-year-old Suresh Chandra, holding his medical files on one hand and prescription letter on the other. Chandra, who is a lung disease patient, moves towards the Jan Aushadhi store, situated in the hospital premises. Chandra hopes that the government-run medical...